Opportunity Information: Apply for PA 18 275
The National Institutes of Health (NIH) funding opportunity PA-18-275, titled "Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R21 Clinical Trial Optional)," supports research that connects mental health and HIV outcomes in practical, measurable ways. The overall aim is to strengthen HIV prevention and treatment by tackling mental health factors that can interfere with engagement in care, medication adherence, and long-term viral suppression. This announcement is designed for investigators who want to either clarify how mental health influences HIV-related behaviors and treatment outcomes, or to build and test new or expanded interventions that improve both mental health and HIV results across the entire HIV care continuum, from initial HIV testing through consistent care and ultimately viral suppression.
A major emphasis of this opportunity is on mechanisms, meaning the underlying pathways that explain why and how mental health conditions (or mental health-related experiences) affect HIV prevention and care outcomes. The FOA encourages studies that move beyond simply documenting that depression, anxiety, trauma, substance use, or other psychological and behavioral health challenges are associated with poorer HIV outcomes. Instead, applicants are expected to dig into what is driving those links and to identify intervention targets that are modifiable, such as specific cognitive, emotional, social, or structural processes that can realistically be changed through prevention or treatment approaches. The goal of this mechanistic focus is to generate actionable knowledge that can directly inform better intervention design, better clinical decision-making, and better implementation strategies in real-world settings.
Alongside mechanism-focused research, the FOA also prioritizes intervention development and early testing. This includes developing and pilot testing "expanded interventions" that address mental health and HIV outcomes together, rather than treating them as separate problems handled in separate systems. The intent is to encourage integrated or coordinated approaches that could improve outcomes at multiple points along the continuum, such as increasing HIV testing uptake, improving linkage to care after diagnosis, supporting retention in care, improving adherence to antiretroviral therapy, and achieving and maintaining viral suppression. Because mental health challenges can affect motivation, decision-making, risk perception, self-efficacy, and the ability to navigate healthcare systems, the NIH is looking for innovative strategies that improve both mental health and HIV prevention/treatment outcomes in tandem.
This specific announcement uses the R21 grant mechanism and is described as "Clinical Trial Optional," which signals that applicants may propose a study that includes a clinical trial component, but they are not required to do so. The R21 is framed as a good fit for high-risk, high-reward projects, especially those that may not yet have extensive preliminary data. It can also be appropriate for projects that use existing datasets or pursue novel ideas that are still at an early stage but could have strong payoff if successful. The FOA contrasts the R21 with a related R01 version (referenced as using the R01 mechanism), where applicants who already have stronger preliminary evidence and/or plan to conduct more extensive work, including longitudinal analysis, might be better positioned to apply under the R01 pathway instead.
In terms of practical funding details included in the source information, this is a discretionary grant opportunity with an award ceiling of $200,000. The funding activity categories are education and health, and the CFDA numbers listed are 93.242 and 93.279. The original closing date shown is 2020-01-07, and the opportunity was created on 2017-11-29. While the listing shows "ExpectedAwards:" without a number provided, the key takeaway is that this was structured as a pilot or early-stage research support mechanism consistent with typical R21 goals: generating proof-of-concept evidence, establishing feasibility, refining intervention components, and producing results that can justify larger-scale research later.
Eligibility is broad and includes a wide range of government, academic, nonprofit, and private-sector organizations. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; and Native American tribal organizations other than federally recognized tribal governments. The FOA also allows nonprofits with and without 501(c)(3) status, for-profit organizations (other than small businesses), and small businesses, along with other categories. It explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, non-U.S. entities (foreign organizations), regional organizations, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions. This wide eligibility scope reflects the reality that HIV prevention and care, as well as mental health services research, often depend on partnerships that span universities, health systems, community organizations, and public agencies, including those serving communities disproportionately affected by HIV and mental health burdens.
Taken together, PA-18-275 is aimed at accelerating innovation at the intersection of mental health and HIV outcomes by funding research that either clarifies the modifiable drivers of mental health-related disparities and drop-offs in the HIV continuum, or tests new integrated strategies that can realistically improve both psychological well-being and HIV prevention/treatment results. The R21 format is positioned as a way to support bold, early-stage ideas and pilot work, with the long-term expectation that successful projects will lay the groundwork for larger trials, broader implementation research, or more definitive longitudinal studies in the future.Apply for PA 18 275
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.279.
- This funding opportunity was created on 2017-11-29.
- Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH PA-18-275 (R21 Clinical Trial Optional)
What is the focus of NIH funding opportunity PA-18-275?
PA-18-275, titled "Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R21 Clinical Trial Optional)," supports research that links mental health and HIV outcomes in practical, measurable ways. The goal is to strengthen HIV prevention and treatment by addressing mental health factors that interfere with engagement in care, medication adherence, and long-term viral suppression.
What is the overall aim of this opportunity?
The overall aim is to improve HIV prevention and treatment outcomes across the HIV care continuum by clarifying how mental health influences HIV-related behaviors and treatment results, and/or by developing and pilot testing interventions that improve both mental health and HIV outcomes together.
What parts of the HIV care continuum are relevant to this FOA?
This FOA is designed to support work spanning the full HIV care continuum, from initial HIV testing through linkage to care, retention in care, adherence to antiretroviral therapy, and achieving and maintaining viral suppression.
What does the FOA mean by emphasizing "mechanisms"?
The emphasis on mechanisms means studies should explain the underlying pathways that account for why and how mental health conditions or mental health-related experiences affect HIV prevention and care outcomes. The FOA encourages applicants to move beyond showing that mental health challenges are associated with poorer HIV outcomes and instead identify what is driving those links.
What kinds of mental health-related issues are considered in scope based on the description?
Based on the provided description, examples include depression, anxiety, trauma, substance use, and other psychological and behavioral health challenges that can affect HIV prevention behaviors and treatment outcomes.
What types of mechanism targets does NIH want applicants to identify?
The FOA highlights the importance of identifying modifiable targets, such as specific cognitive, emotional, social, or structural processes that can realistically be changed through prevention or treatment approaches.
Why is identifying modifiable mechanisms important for this opportunity?
The mechanistic focus is intended to generate actionable knowledge that can directly inform better intervention design, better clinical decision-making, and better implementation strategies in real-world settings.
Does this FOA support intervention research, or only mechanistic research?
It supports both. The FOA prioritizes mechanism-focused research as well as intervention development and early testing, including development and pilot testing of expanded interventions that address mental health and HIV outcomes together.
What are "expanded interventions" in the context of this FOA?
Expanded interventions are approaches that address mental health and HIV outcomes together rather than treating them as separate problems handled in separate systems. The intent is to encourage integrated or coordinated strategies that can improve outcomes at multiple points across the HIV care continuum.
What kinds of outcomes might an integrated intervention try to improve?
Examples mentioned include increasing HIV testing uptake, improving linkage to care after diagnosis, supporting retention in care, improving adherence to antiretroviral therapy, and achieving and maintaining viral suppression, while also improving mental health outcomes.
Why does NIH connect mental health to HIV prevention and care outcomes here?
The FOA notes that mental health challenges can affect motivation, decision-making, risk perception, self-efficacy, and the ability to navigate healthcare systems, which in turn can influence HIV prevention and treatment engagement and outcomes.
What grant mechanism is used for PA-18-275?
This announcement uses the NIH R21 grant mechanism.
What does "R21" imply about the type of work NIH expects?
As described, the R21 is positioned as a good fit for high-risk, high-reward projects and early-stage work that may not yet have extensive preliminary data. It can support proof-of-concept evidence, feasibility work, and refinement of intervention components.
Is a clinical trial required under "Clinical Trial Optional"?
No. "Clinical Trial Optional" means applicants may propose a study that includes a clinical trial component, but they are not required to include a clinical trial.
How does this R21 relate to the R01 pathway referenced in the description?
The description contrasts the R21 with a related R01 version. Applicants with stronger preliminary evidence and/or plans for more extensive work, including longitudinal analysis, may be better positioned for the R01 mechanism, while this R21 supports earlier-stage, pilot, or novel work.
What is the award ceiling mentioned for this opportunity?
The provided information describes an award ceiling of $200,000.
What type of grant is this described as?
It is described as a discretionary grant opportunity.
What are the funding activity categories listed?
The funding activity categories listed are education and health.
What CFDA numbers are associated with this opportunity?
The CFDA numbers listed are 93.242 and 93.279.
When was the opportunity created and what closing date is shown?
The opportunity was created on 2017-11-29, and the original closing date shown is 2020-01-07.
Does the listing specify how many awards NIH expected to make?
The listing shows "ExpectedAwards:" without a number provided, so the number of expected awards is not specified in the provided information.
Who is eligible to apply?
Eligibility is broad and includes many organization types across government, academia, nonprofit, and private sectors. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; and Native American tribal organizations other than federally recognized tribal governments.
Are nonprofits eligible, and does 501(c)(3) status matter?
Yes. The FOA allows nonprofits with and without 501(c)(3) status.
Are for-profit organizations eligible?
Yes. The eligibility list includes for-profit organizations (other than small businesses) as well as small businesses.
Are faith-based and community-based organizations eligible?
Yes. The FOA explicitly highlights faith-based or community-based organizations as eligible applicants.
Are minority-serving institutions specifically mentioned as eligible?
Yes. The FOA highlights Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and other categories.
Are federal agencies eligible to apply?
Yes. The FOA lists eligible federal agencies among additional eligible applicants.
Are non-U.S. (foreign) organizations eligible?
Yes. The FOA includes non-U.S. entities (foreign organizations) as eligible applicants.
Are U.S. territories or possessions eligible?
Yes. The FOA includes U.S. territories or possessions in the eligibility scope.
Does this opportunity encourage cross-sector partnerships?
The description notes that HIV prevention and care and mental health services research often depend on partnerships spanning universities, health systems, community organizations, and public agencies, and the wide eligibility scope reflects that reality.
What is the longer-term expectation for successful R21 projects under this FOA?
The description indicates that successful projects are expected to lay the groundwork for larger trials, broader implementation research, or more definitive longitudinal studies in the future.
Browse more opportunities from the same category: Education, Health
Next opportunity: Systems Biology of Bioenergy-Relevant Microbes to Enable Production of Next-Generation Biofuels and Bioproducts
Previous opportunity: T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 275
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 275) also looked into and applied for these:
| Funding Opportunity |
|---|
| Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01 Clinical Trial Optional) Apply for PAR 18 254 Funding Number: PAR 18 254 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Apply for PAR 18 189 Funding Number: PAR 18 189 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Apply for PAR 18 190 Funding Number: PAR 18 190 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01 Clinical Trial Optional) Apply for PA 18 279 Funding Number: PA 18 279 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional) Apply for PA 18 280 Funding Number: PA 18 280 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional) Apply for PAR 18 249 Funding Number: PAR 18 249 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Health Services Research on Minority Health and Health Disparities (R01 Clinical Trial Optional) Apply for PAR 18 286 Funding Number: PAR 18 286 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Health Services Research on Minority Health and Health Disparities (R21 Clinical Trial Optional) Apply for PAR 18 287 Funding Number: PAR 18 287 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NIDA Program Project Grant Applications (P01, Clinical Trial Optional) Apply for PAR 18 425 Funding Number: PAR 18 425 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Building Evidence: Effective Palliative/End of Life Care Interventions (R01 Clinical Trial Optional) Apply for PAR 18 173 Funding Number: PAR 18 173 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Image-guided Drug Delivery (R01 Clinical Trial Optional) Apply for PAR 18 252 Funding Number: PAR 18 252 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional) Apply for PAR 18 289 Funding Number: PAR 18 289 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 18 224 Funding Number: PAR 18 224 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) Apply for PAR 18 225 Funding Number: PAR 18 225 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 18 292 Funding Number: PAR 18 292 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) Apply for PAR 18 223 Funding Number: PAR 18 223 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional) Apply for PAR 18 250 Funding Number: PAR 18 250 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional) Apply for PAR 18 251 Funding Number: PAR 18 251 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Apply for PAR 18 222 Funding Number: PAR 18 222 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 18 226 Funding Number: PAR 18 226 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 275", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
